Srsly tho virotherapy is ridiculously promising and the most exciting thing going in cancer therapies right now. In a decade or two, we may live in a world where many cancers are cured with a few months of weekly injections that don't do much worse than give you flu syptoms.
That's INSANE.
That's INSANE.
September 15, 2026 at 5:19 PM
Srsly tho virotherapy is ridiculously promising and the most exciting thing going in cancer therapies right now. In a decade or two, we may live in a world where many cancers are cured with a few months of weekly injections that don't do much worse than give you flu syptoms.
That's INSANE.
That's INSANE.
Found out about virotherapy as cancer treatment, HOLY FUCK
BIOLOGY IS SO COOL
BIOLOGY IS SO COOL
September 16, 2026 at 5:23 PM
Found out about virotherapy as cancer treatment, HOLY FUCK
BIOLOGY IS SO COOL
BIOLOGY IS SO COOL
Today on ethical conundrums... a virologist with locally recurrent muscle-invasive breast cancer performed intratumoral oncolytic virotherapy to treat the cancer. Using viruses she prepared in her own lab.
Plot twist: it worked (maybe)
h/t @jasnah.bsky.social
www.mdpi.com/2076-393X/12...
Plot twist: it worked (maybe)
h/t @jasnah.bsky.social
www.mdpi.com/2076-393X/12...
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
Intratumoural oncolytic virotherapy may have promise as a means to debulk and downstage inoperable tumours in preparation for successful surgery. Here, we describe the unique case of a 50-year-old sel...
www.mdpi.com
September 5, 2024 at 10:30 PM
Today on ethical conundrums... a virologist with locally recurrent muscle-invasive breast cancer performed intratumoral oncolytic virotherapy to treat the cancer. Using viruses she prepared in her own lab.
Plot twist: it worked (maybe)
h/t @jasnah.bsky.social
www.mdpi.com/2076-393X/12...
Plot twist: it worked (maybe)
h/t @jasnah.bsky.social
www.mdpi.com/2076-393X/12...
Oncolytic virotherapy is genuinely one of the most exciting frontiers in oncology right now. Hope to see strong results from clinical trials!
September 29, 2026 at 6:11 PM
Oncolytic virotherapy is genuinely one of the most exciting frontiers in oncology right now. Hope to see strong results from clinical trials!
heroic work by the author of this paper. makes me want to stand up and cheer for her. www.mdpi.com/2076-393X/12...
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
Intratumoural oncolytic virotherapy may have promise as a means to debulk and downstage inoperable tumours in preparation for successful surgery. Here, we describe the unique case of a 50-year-old sel...
www.mdpi.com
January 30, 2025 at 6:28 PM
heroic work by the author of this paper. makes me want to stand up and cheer for her. www.mdpi.com/2076-393X/12...
Programming alphavirus with IFN-γ overrides the adverse effects of macrophages on oncolytic virotherapy https://www.biorxiv.org/content/10.1101/2025.02.12.637841v1
February 17, 2025 at 3:17 AM
Programming alphavirus with IFN-γ overrides the adverse effects of macrophages on oncolytic virotherapy https://www.biorxiv.org/content/10.1101/2025.02.12.637841v1
Out today: Oncolytic Virotherapy Plus Nivolumab Is Safe in Muscle-Invasive #BladderCancer, a #ResearchWatch summary of recent clinical findings by Roger Li, James J. Mulé, Jose R. Conejo-Garcia, and colleagues.
aacrjournals.org/cdnews/news/...
aacrjournals.org/cdnews/news/...
Oncolytic Virotherapy Plus Nivolumab Is Safe in Muscle-Invasive Bladder Cancer
Major Finding: A phase 1b trial demonstrated the safety of cretostimogene grenadenorepvec plus nivolumab in muscle-invasive bladder cancer (MIBC).Concept: Boosting immune checkpoint inhibition with on...
aacrjournals.org
December 4, 2024 at 4:00 PM
Out today: Oncolytic Virotherapy Plus Nivolumab Is Safe in Muscle-Invasive #BladderCancer, a #ResearchWatch summary of recent clinical findings by Roger Li, James J. Mulé, Jose R. Conejo-Garcia, and colleagues.
aacrjournals.org/cdnews/news/...
aacrjournals.org/cdnews/news/...
This week's new issue of #ScienceTranslationalMedicine is out now!
An experimental trial could reshape patient monitoring and therapy research in glioblastoma, RNA vaccines can protect large animals from new strains of H5N1, and more. https://scim.ag/3KYkXvi
An experimental trial could reshape patient monitoring and therapy research in glioblastoma, RNA vaccines can protect large animals from new strains of H5N1, and more. https://scim.ag/3KYkXvi
October 8, 2025 at 9:00 PM
This week's new issue of #ScienceTranslationalMedicine is out now!
An experimental trial could reshape patient monitoring and therapy research in glioblastoma, RNA vaccines can protect large animals from new strains of H5N1, and more. https://scim.ag/3KYkXvi
An experimental trial could reshape patient monitoring and therapy research in glioblastoma, RNA vaccines can protect large animals from new strains of H5N1, and more. https://scim.ag/3KYkXvi
I mean I think people should not generally DIY their virotherapy
November 9, 2024 at 1:30 PM
I mean I think people should not generally DIY their virotherapy
Genetic engineering of systemically injectable oncolytic viruses for pyroptosis-accelerated cancer virotherapy @natcancer.nature.com
www.nature.com/articles/s43...
www.nature.com/articles/s43...
January 17, 2026 at 5:27 AM
Genetic engineering of systemically injectable oncolytic viruses for pyroptosis-accelerated cancer virotherapy @natcancer.nature.com
www.nature.com/articles/s43...
www.nature.com/articles/s43...
More info: There is *no evidence* that having a measles infection or receiving the standard measles vaccine protects against future cancer. The origin of this misconception is likely based on ongoing research (genetically engineered measles virus as a direct cancer therapy, oroncolytic virotherapy)
October 7, 2025 at 2:02 PM
More info: There is *no evidence* that having a measles infection or receiving the standard measles vaccine protects against future cancer. The origin of this misconception is likely based on ongoing research (genetically engineered measles virus as a direct cancer therapy, oroncolytic virotherapy)
🥳Happy to share our article on oncolytic virotherapy and T-cell responses influencing outcomes. Key insights: timing of therapy, anticancer T-cell activity, and the diffusion of immune signals all play complex roles, sometimes reducing effectiveness. #Spatialmodel #oncolyticvirus #Stochasticity 💻🎉
Effects of virus-induced immunogenic cues on oncolytic virotherapy - Scientific Reports
Scientific Reports - Effects of virus-induced immunogenic cues on oncolytic virotherapy
www.nature.com
November 23, 2024 at 9:50 PM
🥳Happy to share our article on oncolytic virotherapy and T-cell responses influencing outcomes. Key insights: timing of therapy, anticancer T-cell activity, and the diffusion of immune signals all play complex roles, sometimes reducing effectiveness. #Spatialmodel #oncolyticvirus #Stochasticity 💻🎉
New Journal for ImmunoTherapy of Cancer article: "Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response" jitc.bmj.com/content/14/5...
#JITC #research
#JITC #research
May 21, 2026 at 2:14 PM
New Journal for ImmunoTherapy of Cancer article: "Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response" jitc.bmj.com/content/14/5...
#JITC #research
#JITC #research
We are very proud on our fantastic postdoc Dr. Eleonora Prodi who has been awarded with a prestigious Humboldt-fellowship of @humboldt-foundation.de for her research project @dkfz.bsky.social and @KiTZ on developing a new virotherapy for kids affected by sarcomas!
January 19, 2026 at 11:59 AM
We are very proud on our fantastic postdoc Dr. Eleonora Prodi who has been awarded with a prestigious Humboldt-fellowship of @humboldt-foundation.de for her research project @dkfz.bsky.social and @KiTZ on developing a new virotherapy for kids affected by sarcomas!
To elaborate: oncolytic virotherapy is a type of treatment where cancers are directly infected with viruses in the hopes that the immune response to the virus can result in destruction of the tumor. Currently there are several of these in trials.
September 5, 2024 at 10:31 PM
To elaborate: oncolytic virotherapy is a type of treatment where cancers are directly infected with viruses in the hopes that the immune response to the virus can result in destruction of the tumor. Currently there are several of these in trials.
Open access article on her case study: www.mdpi.com/2076-393X/12...
"An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer"
"An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer"
www.mdpi.com
August 4, 2026 at 6:42 PM
Open access article on her case study: www.mdpi.com/2076-393X/12...
"An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer"
"An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer"
Les résultats ont été publiés dans la revue Vaccines, après une douzaine de refus d'autres éditeurs. www.mdpi.com/2076-393X/12...
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
Intratumoural oncolytic virotherapy may have promise as a means to debulk and downstage inoperable tumours in preparation for successful surgery. Here, we describe the unique case of a 50-year-old sel...
www.mdpi.com
November 21, 2024 at 6:49 AM
Les résultats ont été publiés dans la revue Vaccines, après une douzaine de refus d'autres éditeurs. www.mdpi.com/2076-393X/12...
Yi sui was next with a great talk on multiomic analysis of zika-viral based oncolytic virotherapy
July 7, 2025 at 2:18 PM
Yi sui was next with a great talk on multiomic analysis of zika-viral based oncolytic virotherapy
The potential of oncolytic virotherapy, long discussed in scientific circles, has been dramatically illustrated in one of the most prominent cases of self-treatment.
A scientist, facing a third cancer recurrence, achieved remission through a self-administered viral therapy.
A scientist, facing a third cancer recurrence, achieved remission through a self-administered viral therapy.
Dr. Beata Halassy: How She Used Viruses to Cure Her Breast Cancer — Konsyse
Croatian virologist and immunologist Dr. Beata Halassy used lab grown viruses to cure her recurring breast cancer.
www.konsyse.com
August 29, 2025 at 8:57 AM
The potential of oncolytic virotherapy, long discussed in scientific circles, has been dramatically illustrated in one of the most prominent cases of self-treatment.
A scientist, facing a third cancer recurrence, achieved remission through a self-administered viral therapy.
A scientist, facing a third cancer recurrence, achieved remission through a self-administered viral therapy.
It takes less than five seconds to copy her name & use the interwebs…
🤦♂️
Here!!!
pmc.ncbi.nlm.nih.gov/articles/PMC...
🤦♂️
Here!!!
pmc.ncbi.nlm.nih.gov/articles/PMC...
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
Intratumoural oncolytic virotherapy may have promise as a means to debulk and downstage inoperable tumours in preparation for successful surgery. Here, we describe the unique case of a 50-year-old sel...
pmc.ncbi.nlm.nih.gov
August 4, 2026 at 7:39 PM
It takes less than five seconds to copy her name & use the interwebs…
🤦♂️
Here!!!
pmc.ncbi.nlm.nih.gov/articles/PMC...
🤦♂️
Here!!!
pmc.ncbi.nlm.nih.gov/articles/PMC...
Integrating Oncolytic Virus Engineering and Delivery Strategies for Enhanced Cancer Virotherapy
DOI: https://doi.org/10.1002/agt2.70380
DOI: https://doi.org/10.1002/agt2.70380
July 8, 2026 at 8:11 AM
Integrating Oncolytic Virus Engineering and Delivery Strategies for Enhanced Cancer Virotherapy
DOI: https://doi.org/10.1002/agt2.70380
DOI: https://doi.org/10.1002/agt2.70380
The challenge here is... though this is promising, and the field of oncolytic virotherapy as a whole is promising, we have to be very careful about drawing strong conclusions from a single case report. We have no way of knowing that this procedure actually improved outcomes.
September 5, 2024 at 10:37 PM
The challenge here is... though this is promising, and the field of oncolytic virotherapy as a whole is promising, we have to be very careful about drawing strong conclusions from a single case report. We have no way of knowing that this procedure actually improved outcomes.